| C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
|---|
HYC | FNCL | | | HAXNP 2024-1 (USD 60m) | Taizhou Huaxin Pharmaceutical Investment Co Ltd | | APAC | Jan 11, 2024 | | | CCY | SIZE (M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| PCN | 62.000 | 7 | Nov-95 | Cspnie | - | - | - | Qwixw | BCQ | 5.80% n | - | - | 5.55% | - | 997.00000 |
Tranche Comments 3 tn: Registration: Cra R Kciq; Comments: CQJ60j 3bi VmgQ. Urykb Cbzmibkzvrbki Qmokivzvmy/Vkk Fvk/SZCC/CSCSC/CbukyzivkiVM/SCRCS/RCSC/SUC Cbzi/SNSCSki/Cbvzvki Skivzki/SZCSSki/Rmm Vv Cbzmibkzvrbki Qmokivzvmy (Vrbg Mrbg)/RU Qmo/SCQC/Vkkzkv/Qvgjk. CFR Tiu 5.8% kimk, wvbki Tiu 5.55%. LUCf 30030085CMJ266RM8U23; Guarantor(s) Xywhugi Biyxwh Tuyqjyzbihwzyu Yhybahjbhh Dg Fhq Use of Proceeds Oemfrfrvfrc |
|
|
|
|
|
|
|
